We provide fixed and mobile PET/CT programs to cardiology practices, urology practices, and health systems — putting the most advanced molecular imaging within reach of any provider.
PET/CT is transforming how physicians diagnose and treat disease across oncology, cardiology, neurology, and urology. LDX exists to make that technology accessible to every health system, delivering mobile and fixed PET/CT programs that are operational fast, without the infrastructure burden.
Our mobile solutions deploy quickly to any site, giving health systems immediate access to PET/CT imaging without construction, shielding, or long-term capital commitments.
For health systems ready to build a permanent molecular imaging program, we deliver turnkey fixed PET/CT infrastructure from site planning through first scan.
We convert the capital burden of PET/CT ownership into a predictable operational expense, freeing health systems to invest capital where it matters most.
Every program is backed by OEM service agreements and a 98% uptime commitment, so your imaging program stays operational and your patients stay on schedule.
Serving 48 continental states from Chicago, IL
For health systems ready to build a permanent molecular imaging program. LDX delivers a fully installed and commissioned PET/CT suite, from site planning through go-live, with ongoing OEM-backed service.
Our mobile PET/CT program brings a fully operational scanning unit directly to your site. No construction. No shielding. No capital outlay. A program running in weeks, not years.
Select your organization type to see how LDX serves your specific needs, from large health systems to specialty practices.
Enterprise-scale PET/CT programs across your entire system.
IDNs managing multi-site networks need a partner who can deploy and operate PET/CT programs at scale. LDX delivers mobile and fixed solutions that integrate into your existing infrastructure, converting capital commitments into predictable operational costs across every facility.
How We Help
"One partner to build, operate, and service PET/CT programs across your entire network, without the capital burden of building from scratch at each site."
Launch a PET/CT program without the capital commitment.
Regional and community hospitals often lack the capital budget to build a permanent PET/CT suite but face growing demand for molecular imaging. LDX's mobile program lets you launch quickly, serve your patients, and evaluate fixed installation when the volume justifies it.
How We Help
"Start scanning patients in weeks, not years, without a construction project or capital appropriation."
PET myocardial perfusion imaging, delivered to your site.
Cardiac PET imaging is rapidly replacing SPECT as the standard of care for myocardial perfusion assessment. LDX delivers mobile PET/CT programs that let cardiology practices offer rubidium-82 and F-18 Flyrcado studies without building a dedicated nuclear cardiology suite.
How We Help
"Bring cardiac PET imaging in-house and capture the reimbursement your patients' care already justifies."
PSMA PET/CT for prostate cancer staging and restaging.
PSMA-targeted PET/CT has transformed prostate cancer management, offering superior sensitivity for staging, restaging, and treatment response assessment. LDX provides the mobile PET/CT infrastructure that lets urology and uro-oncology practices access this technology without a fixed installation.
How We Help
"Offer your patients the most advanced prostate cancer imaging available, without the infrastructure investment of a fixed molecular imaging suite."
The imaging backbone of modern cancer care.
PET/CT is the standard of care for staging, treatment planning, and response assessment across virtually every solid tumor type. LDX delivers mobile and fixed PET/CT programs that let oncology practices and cancer centers bring this capability in-house, improving patient experience and capturing imaging revenue.
How We Help
"Keep your patients in-network for PET/CT imaging and capture the revenue that currently flows to hospital outpatient departments."
Amyloid and tau PET imaging for neurodegenerative disease.
Amyloid PET, tau PET, and FDG PET are increasingly central to the diagnosis and management of Alzheimer's disease and other neurodegenerative conditions. LDX provides the mobile and fixed PET/CT infrastructure that neurology practices need to offer these studies without referring out.
How We Help
"Bring amyloid and tau PET imaging in-house as demand accelerates with new Alzheimer's therapeutics entering the market."
Contract-based PET/CT programs for member facilities.
Group purchasing organizations and procurement teams need a reliable partner who can deliver PET/CT programs at scale with consistent quality, documentation, and pricing. LDX supports contract-based deployments across member networks with full traceability and compliance support.
How We Help
"A PET/CT program partner who operates with the transparency and consistency your procurement standards require, at the scale your network demands."
Turnkey PET/CT programs for VA, DoD, and federal healthcare.
VA hospitals, military treatment facilities, and federal healthcare agencies require a complete, compliant PET/CT solution. LDX delivers mobile and fixed PET/CT programs purpose-built to meet federal procurement requirements, with full OEM-backed service and compliance documentation.
How We Help
"One partner for equipment, service, and compliance, purpose-built to meet federal procurement requirements and keep your imaging program fully operational."
Whether you're exploring a mobile PET/CT program, planning a fixed PET/CT installation, or have general questions about our solutions, we want to hear from you.